LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inexpensive Biosensor Provides Rapid Diagnosis of Bacterial Infections

By LabMedica International staff writers
Posted on 11 Dec 2018
Print article
Image: Conceptual representation for the detection of bacteria concentration and proliferation. The electrical signal of the resonator is analyzed through a vector network analyzer (VNA) to gather resonant profile for bacteria in different concentrations and environmental pH, and for long-term screening of their growth (Photo courtesy of the University of British Columbia).
Image: Conceptual representation for the detection of bacteria concentration and proliferation. The electrical signal of the resonator is analyzed through a vector network analyzer (VNA) to gather resonant profile for bacteria in different concentrations and environmental pH, and for long-term screening of their growth (Photo courtesy of the University of British Columbia).
Bacterial infection is a common problem throughout hospitals around the worlds. Every hour of delay in antibiotic treatment increases the mortality rate of patients by 7.6% with sepsis and septic shocks.

The failure to diagnose early and critical stages of bacterial infections can be detrimental to a patient’s health and potentially fatal. The existing methods of diagnosing infections and performing antibiotic susceptibility testing (AST) suffer from a time-consuming and laborious process, typically taking up to 2 to 5 days to obtain accurate and reliable results.

Canadian bioengineers working with the University of British Columbia Okanagan (Kelowna, BC, Canada) have developed a microwave-microfluidic biosensor for rapid, contactless and non-invasive device for testing the concentration and growth of Escherichia coli (E. coli) in medium solutions of different pH to increase the efficacy of clinical microbiology practices. The team tested their device by tracking the amount of bacteria present in a variety of samples under various scenarios. The scenarios resembled those encountered in clinical microbiological laboratories.

The thin layer interface between the microfluidic channel and the microwave resonator significantly enhanced the detection sensitivity. The microfluidic chip, fabricated using standard soft lithography, was injected with bacterial samples and incorporated with a microwave microstrip ring resonator sensor with an operation frequency of 2.5 GHz and initial quality factor of 83 for detecting the concentration and growth of bacteria. The resonator had a coupling gap area on of 1.5 × 1.5 mm2 as of its sensitive region.

The presence of different concentrations of bacteria in different pH solutions was detected via screening the changes in resonant amplitude and frequency responses of the microwave system. The sensor device demonstrated near immediate response to changes in the concentration of bacteria and maximum sensitivity of 3.4 MHz compared to a logarithm value of bacteria concentration. The minimum prepared optical transparency of bacteria was tested at an OD600 value of 0.003. A highly linear response was demonstrated for detecting bacteria concentration at various pH values.

Mohammad Hossein Zarifi, PhD, an assistant professor and co-author of the study, said, “The device is able to rapidly detect bacteria and in addition, it screens the interaction of those bacteria with antibiotics. The combined results give health care practitioners more information than they currently have available, helping them move forward to determine accurate treatments. This biosensor is a significant step forward in improving the complex antibiotic susceptibility testing workflow and provides a rapid and automated detection of bacteria as well as screening the bacteria proliferation in response to antibiotics.” The study was published on October 25, 2018, in the journal Scientific Reports.

Related Links:
University of British Columbia Okanagan

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.